However, people with cardiovascular diseases have increased resting concentrations of circulating FGF21 [11], suggesting either a compensatory cardioprotective effect of FGF21 or FGF21 resistance in cardiovascular disease states. The gene discussed is FGF21; the disease is cardiovascular disorder.